06:45 EDT Merck (MRK) to acquire Terns Pharmaceuticals (TERN) for $53.00 per share in cash
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRK:
- Terns jumps 15% to $57.25 after reports of Merck takeover
- Merck in ‘advanced’ talks to buy Terns Pharma for $6B, FT reports
- Merck Stock (MRK) Looks Bullish — Is the Market Underestimating the Post-Keytruda Playbook?
- Merck Chases $6B Terns Pharma Deal to Boost Cancer Pipeline — Is Keytruda’s Expiry Driving the Panic?
- Merck’s Emerging HIV Franchise: Undervalued Long-Acting Opportunity in a $25B+ Market Supporting a Buy Rating